Report Detail
Global DNA Repair Drugs Market Professional Survey Report 2019
- RnM3733189 |
- 07 September, 2019 |
- Global |
- 117 Pages |
- QYResearch |
- Pharma & Healthcare
DNA damage leads to the incorporation of defects and aberrations in the genome that often result in functional mutations. When these mutations occur in genes coding for vital proteins and/or enzymes, it leads to the development of genetic diseases. However, our biological system is equipped with a robust repair mechanism capable of correcting damaged DNA sequences. PARP inhibitors and other similar therapeutics are designed to augment the body’s innate DNA repair mechanism and aid in the treatment of diseases associated with genetic aberrations.
The global DNA Repair Drugs market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on DNA Repair Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall DNA Repair Drugs market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of DNA Repair Drugs in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their DNA Repair Drugs manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
4SC AG
ARCAGY/ GINECO GROUP
Bristol Myers Squibb
British Columbia Cancer Agency
Cambridge University Hospitals NHS Foundation Trust
Genentech
Georgetown University
German Breast Group
GlaxoSmithKline
Jiangsu Hengrui Medicine
Johnson & Johnson
Jonsson Comprehensive Cancer Center
Karyopharm Therapeutics
KuDOS Pharmaceuticals
National Health Service
National Institutes of Health
Tesaro
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
PARP Inhibitors
Other
Segment by Application
Oncological
Stroke
Table of Contents
Executive Summary
1 Industry Overview of DNA Repair Drugs
- 1.1 Definition of DNA Repair Drugs
- 1.2 DNA Repair Drugs Segment by Type
- 1.2.1 Global DNA Repair Drugs Production Growth Rate Comparison by Types (2014-2025)
- 1.2.2 PARP Inhibitors
- 1.2.3 Other
- 1.3 DNA Repair Drugs Segment by Applications
- 1.3.1 Global DNA Repair Drugs Consumption Comparison by Applications (2014-2025)
- 1.3.2 Oncological
- 1.3.3 Stroke
- 1.4 Global DNA Repair Drugs Overall Market
- 1.4.1 Global DNA Repair Drugs Revenue (2014-2025)
- 1.4.2 Global DNA Repair Drugs Production (2014-2025)
- 1.4.3 North America DNA Repair Drugs Status and Prospect (2014-2025)
- 1.4.4 Europe DNA Repair Drugs Status and Prospect (2014-2025)
- 1.4.5 China DNA Repair Drugs Status and Prospect (2014-2025)
- 1.4.6 Japan DNA Repair Drugs Status and Prospect (2014-2025)
- 1.4.7 Southeast Asia DNA Repair Drugs Status and Prospect (2014-2025)
- 1.4.8 India DNA Repair Drugs Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
- 2.1 Raw Material and Suppliers
- 2.2 Manufacturing Cost Structure Analysis of DNA Repair Drugs
- 2.3 Manufacturing Process Analysis of DNA Repair Drugs
- 2.4 Industry Chain Structure of DNA Repair Drugs
3 Development and Manufacturing Plants Analysis of DNA Repair Drugs
- 3.1 Capacity and Commercial Production Date
- 3.2 Global DNA Repair Drugs Manufacturing Plants Distribution
- 3.3 Major Manufacturers Technology Source and Market Position of DNA Repair Drugs
- 3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
- 4.1 DNA Repair Drugs Production and Capacity Analysis
- 4.2 DNA Repair Drugs Revenue Analysis
- 4.3 DNA Repair Drugs Price Analysis
- 4.4 Market Concentration Degree
5 DNA Repair Drugs Regional Market Analysis
- 5.1 DNA Repair Drugs Production by Regions
- 5.1.1 Global DNA Repair Drugs Production by Regions
- 5.1.2 Global DNA Repair Drugs Revenue by Regions
- 5.2 DNA Repair Drugs Consumption by Regions
- 5.3 North America DNA Repair Drugs Market Analysis
- 5.3.1 North America DNA Repair Drugs Production
- 5.3.2 North America DNA Repair Drugs Revenue
- 5.3.3 Key Manufacturers in North America
- 5.3.4 North America DNA Repair Drugs Import and Export
- 5.4 Europe DNA Repair Drugs Market Analysis
- 5.4.1 Europe DNA Repair Drugs Production
- 5.4.2 Europe DNA Repair Drugs Revenue
- 5.4.3 Key Manufacturers in Europe
- 5.4.4 Europe DNA Repair Drugs Import and Export
- 5.5 China DNA Repair Drugs Market Analysis
- 5.5.1 China DNA Repair Drugs Production
- 5.5.2 China DNA Repair Drugs Revenue
- 5.5.3 Key Manufacturers in China
- 5.5.4 China DNA Repair Drugs Import and Export
- 5.6 Japan DNA Repair Drugs Market Analysis
- 5.6.1 Japan DNA Repair Drugs Production
- 5.6.2 Japan DNA Repair Drugs Revenue
- 5.6.3 Key Manufacturers in Japan
- 5.6.4 Japan DNA Repair Drugs Import and Export
- 5.7 Southeast Asia DNA Repair Drugs Market Analysis
- 5.7.1 Southeast Asia DNA Repair Drugs Production
- 5.7.2 Southeast Asia DNA Repair Drugs Revenue
- 5.7.3 Key Manufacturers in Southeast Asia
- 5.7.4 Southeast Asia DNA Repair Drugs Import and Export
- 5.8 India DNA Repair Drugs Market Analysis
- 5.8.1 India DNA Repair Drugs Production
- 5.8.2 India DNA Repair Drugs Revenue
- 5.8.3 Key Manufacturers in India
- 5.8.4 India DNA Repair Drugs Import and Export
6 DNA Repair Drugs Segment Market Analysis (by Type)
- 6.1 Global DNA Repair Drugs Production by Type
- 6.2 Global DNA Repair Drugs Revenue by Type
- 6.3 DNA Repair Drugs Price by Type
7 DNA Repair Drugs Segment Market Analysis (by Application)
- 7.1 Global DNA Repair Drugs Consumption by Application
- 7.2 Global DNA Repair Drugs Consumption Market Share by Application (2014-2019)
8 DNA Repair Drugs Major Manufacturers Analysis
- 8.1 4SC AG
- 8.1.1 4SC AG DNA Repair Drugs Production Sites and Area Served
- 8.1.2 4SC AG Product Introduction, Application and Specification
- 8.1.3 4SC AG DNA Repair Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.1.4 Main Business and Markets Served
- 8.2 ARCAGY/ GINECO GROUP
- 8.2.1 ARCAGY/ GINECO GROUP DNA Repair Drugs Production Sites and Area Served
- 8.2.2 ARCAGY/ GINECO GROUP Product Introduction, Application and Specification
- 8.2.3 ARCAGY/ GINECO GROUP DNA Repair Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.2.4 Main Business and Markets Served
- 8.3 Bristol Myers Squibb
- 8.3.1 Bristol Myers Squibb DNA Repair Drugs Production Sites and Area Served
- 8.3.2 Bristol Myers Squibb Product Introduction, Application and Specification
- 8.3.3 Bristol Myers Squibb DNA Repair Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.3.4 Main Business and Markets Served
- 8.4 British Columbia Cancer Agency
- 8.4.1 British Columbia Cancer Agency DNA Repair Drugs Production Sites and Area Served
- 8.4.2 British Columbia Cancer Agency Product Introduction, Application and Specification
- 8.4.3 British Columbia Cancer Agency DNA Repair Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.4.4 Main Business and Markets Served
- 8.5 Cambridge University Hospitals NHS Foundation Trust
- 8.5.1 Cambridge University Hospitals NHS Foundation Trust DNA Repair Drugs Production Sites and Area Served
- 8.5.2 Cambridge University Hospitals NHS Foundation Trust Product Introduction, Application and Specification
- 8.5.3 Cambridge University Hospitals NHS Foundation Trust DNA Repair Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.5.4 Main Business and Markets Served
- 8.6 Genentech
- 8.6.1 Genentech DNA Repair Drugs Production Sites and Area Served
- 8.6.2 Genentech Product Introduction, Application and Specification
- 8.6.3 Genentech DNA Repair Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.6.4 Main Business and Markets Served
- 8.7 Georgetown University
- 8.7.1 Georgetown University DNA Repair Drugs Production Sites and Area Served
- 8.7.2 Georgetown University Product Introduction, Application and Specification
- 8.7.3 Georgetown University DNA Repair Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.7.4 Main Business and Markets Served
- 8.8 German Breast Group
- 8.8.1 German Breast Group DNA Repair Drugs Production Sites and Area Served
- 8.8.2 German Breast Group Product Introduction, Application and Specification
- 8.8.3 German Breast Group DNA Repair Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.8.4 Main Business and Markets Served
- 8.9 GlaxoSmithKline
- 8.9.1 GlaxoSmithKline DNA Repair Drugs Production Sites and Area Served
- 8.9.2 GlaxoSmithKline Product Introduction, Application and Specification
- 8.9.3 GlaxoSmithKline DNA Repair Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.9.4 Main Business and Markets Served
- 8.10 Jiangsu Hengrui Medicine
- 8.10.1 Jiangsu Hengrui Medicine DNA Repair Drugs Production Sites and Area Served
- 8.10.2 Jiangsu Hengrui Medicine Product Introduction, Application and Specification
- 8.10.3 Jiangsu Hengrui Medicine DNA Repair Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.10.4 Main Business and Markets Served
- 8.11 Johnson & Johnson
- 8.12 Jonsson Comprehensive Cancer Center
- 8.13 Karyopharm Therapeutics
- 8.14 KuDOS Pharmaceuticals
- 8.15 National Health Service
- 8.16 National Institutes of Health
- 8.17 Tesaro
9 Development Trend of Analysis of DNA Repair Drugs Market
- 9.1 Global DNA Repair Drugs Market Trend Analysis
- 9.1.1 Global DNA Repair Drugs Market Size (Volume and Value) Forecast 2019-2025
- 9.2 DNA Repair Drugs Regional Market Trend
- 9.2.1 North America DNA Repair Drugs Forecast 2019-2025
- 9.2.2 Europe DNA Repair Drugs Forecast 2019-2025
- 9.2.3 China DNA Repair Drugs Forecast 2019-2025
- 9.2.4 Japan DNA Repair Drugs Forecast 2019-2025
- 9.2.5 Southeast Asia DNA Repair Drugs Forecast 2019-2025
- 9.2.6 India DNA Repair Drugs Forecast 2019-2025
- 9.3 DNA Repair Drugs Market Trend (Product Type)
- 9.4 DNA Repair Drugs Market Trend (Application)
- 10.1 Marketing Channel
- 10.1.1 Direct Marketing
- 10.1.2 Indirect Marketing
- 10.3 DNA Repair Drugs Customers
11 Market Dynamics
- 11.1 Market Trends
- 11.2 Opportunities
- 11.3 Market Drivers
- 11.4 Challenges
- 11.5 Influence Factors
12 Conclusion
13 Appendix
- 13.1 Methodology/Research Approach
- 13.1.1 Research Programs/Design
- 13.1.2 Market Size Estimation
- 13.1.3 Market Breakdown and Data Triangulation
- 13.2 Data Source
- 13.2.1 Secondary Sources
- 13.2.2 Primary Sources
- 13.3 Author List
Summary:
Get latest Market Research Reports on DNA Repair Drugs. Industry analysis & Market Report on DNA Repair Drugs is a syndicated market report, published as Global DNA Repair Drugs Market Professional Survey Report 2019. It is complete Research Study and Industry Analysis of DNA Repair Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
